Back
Keros Therapeutics Vs. Eli Lilly and Industry Stock Comparison
Buy
68
KROS
Keros Therapeutics
Last Price:
59.23
Seasonality Move:
45.94%
Buy
56
LLY
Eli Lilly and
Last Price:
909.25
Seasonality Move:
5.15%
Buy
68
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $59.33. The Score for KROS is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $909.15. The Score for LLY is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $59.33
The current trend is moderately bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $909.15
The current trend is moderately bearish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.74 | Buy |
Relative Strength Index (14 RSI): | 54.42 | Buy |
Chaikin Money Flow: | -73900 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.33 - 60.71) | Buy |
Bollinger Bands (100): | (44.91 - 56.17) | Buy |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.09 | Buy |
Relative Strength Index (14 RSI): | 49.09 | Sell |
Chaikin Money Flow: | 856047 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (893.18 - 923.1) | Buy |
Bollinger Bands (100): | (848.91 - 938.87) | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 60.18 | Sell |
20-day SMA: | 59.23 | Buy |
50-day SMA: | 53.7 | Buy |
200-day SMA: | 54.65 | Buy |
8-day EMA: | 60.13 | Sell |
20-day EMA: | 58.89 | Buy |
50-day EMA: | 55.53 | Buy |
200-day EMA: | 51.4 | Buy |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 916.91 | Sell |
20-day SMA: | 906.87 | Buy |
50-day SMA: | 919.94 | Sell |
200-day SMA: | 815.68 | Buy |
8-day EMA: | 912.61 | Sell |
20-day EMA: | 911.27 | Sell |
50-day EMA: | 905.42 | Buy |
200-day EMA: | 811.42 | Buy |
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and a decrease next year of $0.47 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $4.83 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.09 per share, and an increase next year of $9.61 per share.
Keros Therapeutics Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |